Skip to main content

Dopamine Psychosis in Schizophrenia? Molecular Genetic Study on Delusional Disorder

  • Chapter
Catecholamine Research

Part of the book series: Advances in Behavioral Biology ((ABBI,volume 53))

  • 16 Accesses

Abstract

Delusional disorder is characterized by mono-symptomatic paranoid symptoms without other schizophrenic symptoms. Thus, delusional disorder can be a good clinical model for investigating the molecular genetic mechanisms for paranoid symptoms. In this study, we hypothesized that a hyperdopaminergic state in the brain is responsible for producing paranoid symptoms. To test this hypothesis, we (1) compared neuroleptic responses between patients with delusional disorder and schizophrenia, (2) measured plasma levels of homovanillic acid (pHVA), an indicator of brain dopamine activity, in patients with delusional disorder, and (3) analysed the polymorphism of dopamine receptors (DRs) and its synthesizing enzyme gene.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Garver DL, Steinberg JL, McDermott BE, et al: Etiologic heterogeneity of the psychoses: is there a dopamine psychosis? Neuropsychopharmacol 14:191–201, 1997.

    Article  Google Scholar 

  • Arinami T, Itokawa M, Enguchi H, et al: Association of dopamine D2 receptor molecular variant with schizophrenia. Lancet 343:703–704, 1994.

    Article  PubMed  CAS  Google Scholar 

  • Arinami T, Itokawa M, Aoki J, et al: Further association study on dopamine D2 receptor variant S311C in schizophrenia and affective disorder. Am J Med Genet 67:133–138, 1996.

    Article  PubMed  CAS  Google Scholar 

  • Serretti A, Latuada E, Lorenzi R, et al: Dopamine receptor D2 Ser/Cys311 is associated with delusion and disorganization symptomatology in major psychoses. Mol Psychiatry 5:270–274, 2000.

    Article  PubMed  CAS  Google Scholar 

  • Crocq MA, Mant R, Asherson P, et al: Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J Med Genet 29:858–860, 1992.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

Morimoto, K., Miyatake, R., Nakamura, M. (2002). Dopamine Psychosis in Schizophrenia? Molecular Genetic Study on Delusional Disorder. In: Nagatsu, T., Nabeshima, T., McCarty, R., Goldstein, D.S. (eds) Catecholamine Research. Advances in Behavioral Biology, vol 53. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-3538-3_98

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-3538-3_98

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4419-3388-1

  • Online ISBN: 978-1-4757-3538-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics